Date: 2.9.2013
Technology offer: Complement inhibitors for the treatment of immune system diseases.
Reference: TOES20130802002
Summary: Two Spanish public research organizations have developed an antibody that reacts preventing or modulating complement system activity. The antibody lock effectively the generation of the C3 convertase of the alternative pathway of complement activation, whose deregulation is related to different illness such as multiple sclerosis and ischemia among others. The researchers are looking for biotech or pharmaceutical companies for a further development under a patent license.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Biotechnology events - Database of international biotechnology events.
Microbes stomp daffodils in creating valuable anti-Alzheimer\'s drug
DNA particles that mimic viruses hold promise as vaccines